- Home
- EUDA vs BRNS Comparison
EUDA vs BRNS Comparison
Compare EUDA & BRNS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | EUDA | BRNS |
|---|---|---|
| Founded | 2021 | 2016 |
| Country | Singapore | United Kingdom |
| Employees | N/A | N/A |
| Industry | Blank Checks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 68.7M | 55.9M |
| IPO Year | N/A | 2021 |
Fundamental Metrics
Financial Performance| Metric | EUDA | BRNS |
|---|---|---|
| Price | $2.35 | $0.68 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 1 |
| Target Price | N/A | ★ $4.00 |
| AVG Volume (30 Days) | ★ 650.1K | 78.4K |
| Earning Date | 12-19-2023 | 11-07-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ 0.01 | N/A |
| Revenue | ★ $5,160,280.00 | N/A |
| Revenue This Year | $137.25 | N/A |
| Revenue Next Year | $361.43 | N/A |
| P/E Ratio | $323.38 | ★ N/A |
| Revenue Growth | 83.73 | ★ 1766.46 |
| 52 Week Low | $1.03 | $0.64 |
| 52 Week High | $4.70 | $2.92 |
Technical Indicators
Market Signals| Indicator | EUDA | BRNS |
|---|---|---|
| Relative Strength Index (RSI) | 48.25 | 36.76 |
| Support Level | $1.21 | $0.66 |
| Resistance Level | $2.96 | $0.77 |
| Average True Range (ATR) | 0.54 | 0.06 |
| MACD | 0.00 | 0.01 |
| Stochastic Oscillator | 66.17 | 23.06 |
Price Performance
Historical ComparisonAbout EUDA EUDA Health Holdings Limited
EUDA Health Holdings Ltd is a non-invasive healthcare company across Southeast Asia and China. The Company has two reportable segments: property management services and holistic wellness consumer products and services. Key revenue is generated from property management services that include common area property management services that contain cleaning, landscaping, public facilities maintenance and other traditional services and also include security property management services provided to all tenants and property owners.
About BRNS Barinthus Biotherapeutics plc
Barinthus Biotherapeutics PLC is a clinical-stage biopharmaceutical company developing novel T-cell immunotherapeutics that guide the immune system to overcome chronic infectious diseases, autoimmunity, and cancer. The company operates as one segment, the research and development of immunotherapies and vaccines.